In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

All News Releases

Stanford study finds that whole-genome sequencing for clinical use faces many challenges
NCI Cancer Center News
(Posted: 03/12/2014) - Whole-genome sequencing is a powerful technology, but a new Stanford study shows that significant challenges must be overcome before it can be routinely clinically useful.

Harvard researchers find that a common mutation is culprit in acute leukemia relapse
NCI Cancer Center News
(Posted: 03/10/2014) - Harvard stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse.

UCSF study says E-cigarettes are a possible gateway to nicotine addiction for U.S. teens
NCI Cancer Center News
(Posted: 03/10/2014) - E-cigarettes, promoted as a way to quit regular cigarettes, may actually be a new route to conventional smoking and nicotine addiction for teenagers, according to a new UC San Francisco study.

UCSD researchers find that anti-psychotic medications offer new hope in the battle against glioblastoma
NCI Cancer Center News
(Posted: 03/10/2014) - Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma.

UTSW researchers identify target for shutting down growth of prostate cancer cells
NCI Cancer Center News
(Posted: 03/10/2014) - Dr. Ralf Kittler's lab found that an enzyme called USP9X protects ERG from degradation in prostate cancer cells and subsequently found that a molecule called WP1130 can block USP9X and lead to the destruction of ERG.

Harvard study finds that younger men benefit most from surgery for localized prostate cancer
NCI Cancer Center News
(Posted: 03/06/2014) - New study finds a substantial long-term reduction in mortality for men with localized cancer who undergo a radical prostatectomy.

Hopkins and Dana-Farber researchers report that immune system-based therapy produces lasting remissions in melanoma patients
NCI Cancer Center News
(Posted: 03/06/2014, Updated: 03/06/2014) - Nivolumab, a drug that unleashes the immune system to attack cancer, is now shown to produce lasting remissions and hold the disease in check in many patients with advanced melanoma.

Dana-Farber study shows more hospital deaths and invasive care for dying cancer patients who receive chemotherapy
NCI Cancer Center News
(Posted: 03/05/2014) - Terminal cancer patients who receive chemotherapy in the last months of their lives are less likely to die where they want and are more likely to undergo invasive medical procedures than those who do not receive chemotherapy.

Purdue study of cholesterol-metabolism suggests new diagnostic, treatment approach for aggressive prostate cancer
NCI Cancer Center News
(Posted: 03/05/2014) - Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells.

MD Anderson researchers find that yoga regulates stress hormones
NCI Cancer Center News
(Posted: 03/05/2014) - Through a grant from the National Cancer Institute, researchers are now conducting a Phase III clinical trial in women with breast cancer to further determine the mechanisms of yoga that lead to improvement in physical functioning and quality of life.

< Previous  9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  Next >